Simeprevir

#	Item
31	OLYSIO™ (simeprevir) Receives FDA Approval for Combination Treatment of Chronic Hepatitis C OLYSIO™is the first once-daily protease inhibitor approved for the treatment of chronic Add to Reading List Source URL: www.hepcassoc.org Language: English - Date: 2013-12-05 14:03:19 Medicine Organic chemistry Boceprevir Telaprevir Ribavirin Interferon Hepatitis C Darunavir Hepatitis C and HIV co-infection Protease inhibitors Antivirals Pharmacology
32	Simeprevir Administered Once Daily as Part of Combination Therapy Demonstrates Sustained Virologic Response in Treatment-Naïve and Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients Add to Reading List Source URL: www.hepcassoc.org Language: English - Date: 2013-11-07 14:20:10 Biology Ribavirin Interferon Hepatitis C PEGylation Pegylated interferon Peginterferon alfa-2a Hepatitis C and HIV co-infection Antivirals Pharmacology Medicine